13F-HR filed by BB BIOTECH AG
BB BIOTECH AG filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-11, with 28 holding rows worth $3,271,610,000.
- Accession
- 0000950123-17-007391
- Filer
- CIK 924223
- Filed
- 2017-08-11
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 28 entries on the cover page, a total value of $3,271,610,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,271,610,000 with VALUE read as thousands by filing date, 13F file number 028-06964. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBiotech Focus N V 028-11193
- included managerBiotech Invest N V 028-11191
- included managerBiotech Target N V 028-11189
- included managerBiotech Growth N V 028-11194
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INCYTE CORP COM | 45337C102 | Stock | 3,514,822 | $442,551,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 3,249,298 | $421,986,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 7,354,095 | $374,103,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 5,038,799 | $227,905,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 2,774,596 | $196,386,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 1,475,445 | $190,141,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 1,354,428 | $164,793,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 3,446,552 | $158,541,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 2,869,528 | $147,637,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 877,990 | $122,796,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 8,265,304 | $105,961,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,221,338 | $97,414,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 180,000 | $88,405,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 907,439 | $72,268,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,513,542 | $70,047,000 | thousands by filing date | |
| KITE PHARMA INC | 49803L109 | COM | 640,000 | $66,349,000 | thousands by filing date | |
| JUNO THERAPEUTICS INC | 48205A109 | COM | 2,185,000 | $65,310,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 2,350,112 | $41,150,000 | thousands by filing date | |
| MYOVANT SCIENCES LTD | G637AM102 | COMMON STOCK-FO | 3,317,171 | $38,811,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 402,800 | $33,094,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 255,719 | $30,960,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 2,150,000 | $26,703,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 777,500 | $23,411,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,941,008 | $22,225,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 350,000 | $18,942,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 8,330,000 | $9,580,000 | thousands by filing date | |
| CIDARA THERAPEUTICS INC COM NEW | 171757107 | Stock | 1,102,578 | $8,269,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,279,340 | $5,872,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-17-007391 | this filing | 2017-08-11 | acceptance time not in the bulk data set |